2,3-Dihydroxypropyl oleate is a lipid of Glycerolipids (GL) class. The involved functions are known as enzyme activity and acyltransferase activity. 2,3-dihydroxypropyl oleate often locates in soluble fraction.
To understand associated biological information of 2,3-Dihydroxypropyl oleate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
There are no associated biomedical information in the current reference collection.
We collected disease MeSH terms mapped to the references associated with 2,3-Dihydroxypropyl oleate
| MeSH term | MeSH ID | Detail |
|---|---|---|
| Burns | D002056 | 34 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Edema | D004487 | 152 associated lipids |
| Arthritis | D001168 | 41 associated lipids |
| Abscess | D000038 | 13 associated lipids |
| Psoriasis | D011565 | 47 associated lipids |
| Hypertension, Renovascular | D006978 | 10 associated lipids |
| Blood Loss, Surgical | D016063 | 6 associated lipids |
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
| Location | Cross reference | Weighted score | Related literatures |
|---|
| Function | Cross reference | Weighted score | Related literatures |
|---|
There are no associated biomedical information in the current reference collection.
There are no associated biomedical information in the current reference collection.
There are no associated biomedical information in the current reference collection.
| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Sanandaji N et al. | Comparison of oligonucleotide migration in a bicontinuous cubic phase of monoolein and water and in a fibrous agarose hydrogel. | 2006 | Electrophoresis | pmid:16807936 |
| Zawalich WS and Zawalich KC | Forskolin-induced desensitization of pancreatic beta-cell insulin secretory responsiveness: possible involvement of impaired information flow in the inositol-lipid cycle. | 1990 | Endocrinology | pmid:1691696 |
| Zawalich WS et al. | Interleukin-1 alpha exerts glucose-dependent stimulatory and inhibitory effects on islet cell phosphoinositide hydrolysis and insulin secretion. | 1989 | Endocrinology | pmid:2539976 |
| Zawalich WS | Phosphoinositide hydrolysis and insulin secretion in response to glucose stimulation are impaired in isolated rat islets by prolonged exposure to the sulfonylurea tolbutamide. | 1989 | Endocrinology | pmid:2544404 |
| Zhu Q et al. | A two-stage enzymatic process for synthesis of extremely pure high oleic glycerol monooleate. | 2011 | Enzyme Microb. Technol. | pmid:22112823 |
| Esposito E et al. | Nanoparticulate lipid dispersions for bromocriptine delivery: characterization and in vivo study. | 2012 | Eur J Pharm Biopharm | pmid:22061262 |
| Shah MH and Paradkar A | Effect of HLB of additives on the properties and drug release from the glyceryl monooleate matrices. | 2007 | Eur J Pharm Biopharm | pmid:17353118 |
| Wörle G et al. | Effect of drug loading on the transformation of vesicular into cubic nanoparticles during heat treatment of aqueous monoolein/poloxamer dispersions. | 2006 | Eur J Pharm Biopharm | pmid:16497495 |
| Lopes LB et al. | Liquid crystalline phases of monoolein and water for topical delivery of cyclosporin A: characterization and study of in vitro and in vivo delivery. | 2006 | Eur J Pharm Biopharm | pmid:16621488 |
| Ahmed AR et al. | Reduction in burst release of PLGA microparticles by incorporation into cubic phase-forming systems. | 2008 | Eur J Pharm Biopharm | pmid:18692569 |
| Vicentini FT et al. | Liquid crystalline phase nanodispersions enable skin delivery of siRNA. | 2013 | Eur J Pharm Biopharm | pmid:23010565 |
| Bittner B et al. | The use of election paramagnetic resonance spectroscopy in early preformulation experiments: the impact of different experimental formulations on the release of a lipophilic spin probe into gastric juice. | 2001 | Eur J Pharm Biopharm | pmid:11226824 |
| Morsi NM et al. | Silver sulfadiazine based cubosome hydrogels for topical treatment of burns: development and in vitro/in vivo characterization. | 2014 | Eur J Pharm Biopharm | pmid:23688805 |
| Sallam AS et al. | Formulation of an oral dosage form utilizing the properties of cubic liquid crystalline phases of glyceryl monooleate. | 2002 | Eur J Pharm Biopharm | pmid:11976023 |
| Esposito E et al. | Effect of nanostructured lipid vehicles on percutaneous absorption of curcumin. | 2014 | Eur J Pharm Biopharm | pmid:24361485 |
| Tiossi RF et al. | In vitro and in vivo evaluation of the delivery of topical formulations containing glycoalkaloids of Solanum lycocarpum fruits. | 2014 | Eur J Pharm Biopharm | pmid:24509413 |
| Donida B et al. | Monoolein-based nanoparticles for drug delivery to the central nervous system: A platform for lysosomal storage disorder treatment. | 2018 | Eur J Pharm Biopharm | pmid:30315863 |
| Vithani K et al. | Solubilisation behaviour of poorly water-soluble drugs during digestion of solid SMEDDS. | 2018 | Eur J Pharm Biopharm | pmid:29981444 |
| Ahmed AR and Bodmeier R | Preparation of preformed porous PLGA microparticles and antisense oligonucleotides loading. | 2009 | Eur J Pharm Biopharm | pmid:18840521 |
| Simonetti LD et al. | Assessment of the percutaneous penetration of cisplatin: the effect of monoolein and the drug skin penetration pathway. | 2009 | Eur J Pharm Biopharm | pmid:19442727 |